- Home
- LYB vs DGX Comparison
LYB vs DGX Comparison
Compare LYB & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYB
- DGX
- Stock Information
- Founded
- LYB 1955
- DGX 1967
- Country
- LYB United States
- DGX United States
- Employees
- LYB N/A
- DGX N/A
- Industry
- LYB Major Chemicals
- DGX Medical Specialities
- Sector
- LYB Industrials
- DGX Health Care
- Exchange
- LYB Nasdaq
- DGX Nasdaq
- Market Cap
- LYB 20.3B
- DGX 20.5B
- IPO Year
- LYB N/A
- DGX 1996
- Fundamental
- Price
- LYB $52.60
- DGX $180.70
- Analyst Decision
- LYB Hold
- DGX Buy
- Analyst Count
- LYB 14
- DGX 15
- Target Price
- LYB $65.71
- DGX $185.40
- AVG Volume (30 Days)
- LYB 4.2M
- DGX 698.2K
- Earning Date
- LYB 10-31-2025
- DGX 10-21-2025
- Dividend Yield
- LYB 10.41%
- DGX 1.77%
- EPS Growth
- LYB N/A
- DGX 12.66
- EPS
- LYB 0.77
- DGX 8.35
- Revenue
- LYB $38,655,000,000.00
- DGX $10,522,000,000.00
- Revenue This Year
- LYB N/A
- DGX $11.12
- Revenue Next Year
- LYB $0.35
- DGX $3.41
- P/E Ratio
- LYB $68.19
- DGX $21.68
- Revenue Growth
- LYB 2.98
- DGX 12.58
- 52 Week Low
- LYB $47.55
- DGX $146.17
- 52 Week High
- LYB $97.60
- DGX $185.62
- Technical
- Relative Strength Index (RSI)
- LYB 39.98
- DGX 52.20
- Support Level
- LYB $52.68
- DGX $179.77
- Resistance Level
- LYB $56.10
- DGX $185.05
- Average True Range (ATR)
- LYB 1.69
- DGX 2.58
- MACD
- LYB -0.03
- DGX -0.19
- Stochastic Oscillator
- LYB 3.33
- DGX 45.69
About LYB LyondellBasell Industries NV (Netherlands)
LyondellBasell is a petrochemical producer with operations in the United States, Europe, and Asia. The company is the world's largest producer of polypropylene and also a major producer of polyethylene and propylene oxide. Its chemicals are used in various consumer and industrial end products. Well over half of LyondellBasell's production comes from its North American operations.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.